These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 56956)

  • 1. Current questions on the tumour-associated antigens of chemically-induced tumours. I. In search of their characterization.
    Oth D
    Biomedicine; 1975 Sep; 22(5):350-7. PubMed ID: 56956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current questions on the tumour-associated antigens of chemically-induced tumours II. In search of practical uses.
    Oth D
    Biomedicine; 1976 Jan; 24(1):4-10. PubMed ID: 57809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune response and neoplasia.
    Stutman O; Good RA
    Adv Biol Skin; 1971; 11():357-85. PubMed ID: 4124145
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunology and malignant disease.
    Klein E; Cochran AJ
    Haematologia (Budap); 1971; 5(3):179-203. PubMed ID: 4108507
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies of virus-specific antigenicity of tumour cells transformed by bovine adenovirus type 3.
    Strizhachenko NM; Graevskaya NA; Karmysheva VY; Syurin VN
    Arch Geschwulstforsch; 1975; 45(4):324-34. PubMed ID: 1200779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Tumour antigens inducing immune reactions].
    Burtin P
    Ann Immunol (Paris); 1977; 128(1-2):507-16. PubMed ID: 192132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comments on the relationships between H-2 antigens and other antigens in the mouse, with special reference to possible implications for the host-tumour systems.
    Oth D; Meyer G; Berebbi M
    Folia Biol (Praha); 1977 Jan; 23(1):1-18. PubMed ID: 66159
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunogenetic approach to neoplasia.
    Tennant JR
    Transplant Proc; 1970 Mar; 2(1):104-16. PubMed ID: 4107289
    [No Abstract]   [Full Text] [Related]  

  • 9. Dissection of tumour-specific antigenicity.
    Wortzel RD; Stauss HJ; Van Waes C; Schreiber H
    Cancer Surv; 1985; 4(1):115-34. PubMed ID: 3879854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies of tumor antigens and tumor-specific immune mechanisms in experimental systems.
    Law LW
    Transplant Proc; 1970 Mar; 2(1):117-32. PubMed ID: 4330038
    [No Abstract]   [Full Text] [Related]  

  • 11. Tumour specific transplantation antigens of chemically induced rodent tumours.
    Evan GI; Lennox ES; Lowe AD; Cohn JD
    Prog Clin Biol Res; 1983; 132B():355-61. PubMed ID: 6195668
    [No Abstract]   [Full Text] [Related]  

  • 12. The molecular nature of multiple tumour-associated antigens expressed by a Rauscher-MuLV induced leukaemia.
    Rogers MJ; Galetto G
    Cancer Surv; 1985; 4(1):35-49. PubMed ID: 3842316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell surface antigens of chemically induced sarcomas of murine origin.
    DeLeo AB; Srivastava PK
    Cancer Surv; 1985; 4(1):21-34. PubMed ID: 3022922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumour specific antigens associated with chemically induced tumours.
    Baldwin RW
    Rev Eur Etud Clin Biol; 1970; 15(6):593-8. PubMed ID: 4319386
    [No Abstract]   [Full Text] [Related]  

  • 15. Common tumor rejection antigens in methylcholanthrene-induced squamous cell carcinomas of mice detected by tumor protection and a radioisotopic footpad assay.
    Economou GC; Takelchi N; Boone CW
    Cancer Res; 1977 Jan; 37(1):37-41. PubMed ID: 63329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. H-2 antigens and tumour-associated transplantation antigens in clones derived from a methylcholanthrene-induced BALB/c tumour: their influence on the generation in vitro and in vivo of the specific anti-tumour immune response.
    Pérez M; Garrido A; Algarra I; Caballero A; Delgado C; Collado MD; Fernández-Cruz E; Garrido F
    Exp Clin Immunogenet; 1989; 6(3):204-18. PubMed ID: 2631798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The nature and clinical significance of tumor immunology].
    Götz H
    Med Klin; 1973 Sep; 68(38):1217-22. PubMed ID: 4583599
    [No Abstract]   [Full Text] [Related]  

  • 18. Viral aetiopathogenesis of tumors.
    Klein E
    Boll Ist Sieroter Milan; 1971; 50(3):140-51. PubMed ID: 4111986
    [No Abstract]   [Full Text] [Related]  

  • 19. Demonstration of cross-reacting tumor rejection antigens in chemically induced respiratory tract carcinomas in rats.
    Jamasbi RJ; Nettesheim P
    Cancer Res; 1977 Nov; 37(11):4059-63. PubMed ID: 71203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of tumour rejection antigens recognized by T lymphocytes.
    Boon T; De Plaen E; Lurquin C; Van den Eynde B; van der Bruggen P; Traversari C; Amar-Costesec A; Van Pel A
    Cancer Surv; 1992; 13():23-37. PubMed ID: 1423324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.